Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase

Citation
H. Duplain et al., Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase, CIRCULATION, 104(3), 2001, pp. 342-345
Citations number
27
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CIRCULATION
ISSN journal
00097322 → ACNP
Volume
104
Issue
3
Year of publication
2001
Pages
342 - 345
Database
ISI
SICI code
0009-7322(20010717)104:3<342:IRHAHI>2.0.ZU;2-R
Abstract
Background - Insulin resistance and arterial hypertension are related, but the underlying mechanism is unknown. Endothelial nitric oxide synthase (eNO S) is expressed in skeletal muscle, where it may govern metabolic processes , and in the vascular endothelium, where it regulates arterial pressure. Methods and Results - To study the role of eNOS in the control of the metab olic action of insulin, we assessed insulin sensitivity in conscious mice w ith disruption of the gene encoding for eNOS. eNOS(-/-) mice were hypertens ive and had fasting hyperinsulinemia, hyperlipidemia, and a 40% lower insul in-stimulated glucose uptake than control mice. Insulin resistance in eNOS( -/-) mice was related specifically to impaired NO synthesis, because in equ ally hypertensive 1-kidney/1-clip mice (a model of renovascular hypertensio n), insulin-stimulated glucose uptake was normal. Conclusions - These results indicate that eNOS is important for the control not only of arterial pressure but also of glucose and lipid homeostasis. A single gene defect, eNOS deficiency, may represent the link between metabo lic and cardiovascular disease.